Literature DB >> 28923909

Response by Bress et al to Letters Regarding Article, "Potential Deaths Averted and Serious Adverse Events Incurred From Adoption of the SPRINT (Systolic Blood Pressure Intervention Trial) Intensive Blood Pressure Regimen in the United States: Projections from NHANES (National Health and Nutrition Examination Survey)".

Adam P Bress1, Holly Kramer1, Richard S Cooper1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28923909      PMCID： PMC5659344          DOI： 10.1161/CIRCULATIONAHA.117.029937

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  6 in total

1.  Potential Deaths Averted and Serious Adverse Events Incurred From Adoption of the SPRINT (Systolic Blood Pressure Intervention Trial) Intensive Blood Pressure Regimen in the United States: Projections From NHANES (National Health and Nutrition Examination Survey).

Authors:  Adam P Bress; Holly Kramer; Rasha Khatib; Srinivasan Beddhu; Alfred K Cheung; Rachel Hess; Vinod K Bansal; Guichan Cao; Jerry Yee; Andrew E Moran; Ramon Durazo-Arvizu; Paul Muntner; Richard S Cooper
Journal:  Circulation       Date:  2017-02-13       Impact factor: 29.690

2.  Unfounded concerns about the use of automated office blood pressure measurement in SPRINT.

Authors:  Martin G Myers; Norm R C Campbell
Journal:  J Am Soc Hypertens       Date:  2016-10-21

3.  Systolic Blood Pressure Reduction and Risk of Cardiovascular Disease and Mortality: A Systematic Review and Network Meta-analysis.

Authors:  Joshua D Bundy; Changwei Li; Patrick Stuchlik; Xiaoqing Bu; Tanika N Kelly; Katherine T Mills; Hua He; Jing Chen; Paul K Whelton; Jiang He
Journal:  JAMA Cardiol       Date:  2017-07-01       Impact factor: 14.676

4.  Guideline for the diagnosis and management of hypertension in adults - 2016.

Authors:  Genevieve M Gabb; Arduino A Mangoni; Craig S Anderson; Diane Cowley; John S Dowden; Jonathan Golledge; Graeme J Hankey; Faline S Howes; Les Leckie; Vlado Perkovic; Markus Schlaich; Nicholas A Zwar; Tanya L Medley; Leonard Arnolda
Journal:  Med J Aust       Date:  2016-07-18       Impact factor: 7.738

5.  Hypertension Canada's 2016 Canadian Hypertension Education Program Guidelines for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension.

Authors:  Alexander A Leung; Kara Nerenberg; Stella S Daskalopoulou; Kerry McBrien; Kelly B Zarnke; Kaberi Dasgupta; Lyne Cloutier; Mark Gelfer; Maxime Lamarre-Cliche; Alain Milot; Peter Bolli; Guy Tremblay; Donna McLean; Sheldon W Tobe; Marcel Ruzicka; Kevin D Burns; Michel Vallée; G V Ramesh Prasad; Marcel Lebel; Ross D Feldman; Peter Selby; Andrew Pipe; Ernesto L Schiffrin; Philip A McFarlane; Paul Oh; Robert A Hegele; Milan Khara; Thomas W Wilson; S Brian Penner; Ellen Burgess; Robert J Herman; Simon L Bacon; Simon W Rabkin; Richard E Gilbert; Tavis S Campbell; Steven Grover; George Honos; Patrice Lindsay; Michael D Hill; Shelagh B Coutts; Gord Gubitz; Norman R C Campbell; Gordon W Moe; Jonathan G Howlett; Jean-Martin Boulanger; Ally Prebtani; Pierre Larochelle; Lawrence A Leiter; Charlotte Jones; Richard I Ogilvie; Vincent Woo; Janusz Kaczorowski; Luc Trudeau; Robert J Petrella; Swapnil Hiremath; Denis Drouin; Kim L Lavoie; Pavel Hamet; George Fodor; Jean C Grégoire; Richard Lewanczuk; George K Dresser; Mukul Sharma; Debra Reid; Scott A Lear; Gregory Moullec; Milan Gupta; Laura A Magee; Alexander G Logan; Kevin C Harris; Janis Dionne; Anne Fournier; Geneviève Benoit; Janusz Feber; Luc Poirier; Raj S Padwal; Doreen M Rabi
Journal:  Can J Cardiol       Date:  2016-03-10       Impact factor: 5.223

6.  A Randomized Trial of Intensive versus Standard Blood-Pressure Control.

Authors:  Jackson T Wright; Jeff D Williamson; Paul K Whelton; Joni K Snyder; Kaycee M Sink; Michael V Rocco; David M Reboussin; Mahboob Rahman; Suzanne Oparil; Cora E Lewis; Paul L Kimmel; Karen C Johnson; David C Goff; Lawrence J Fine; Jeffrey A Cutler; William C Cushman; Alfred K Cheung; Walter T Ambrosius
Journal:  N Engl J Med       Date:  2015-11-09       Impact factor: 91.245
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.